Joint statement and recommendations on vitamin K administration to newborn infants to prevent vitamin K deficiency bleeding in infancy

Summary information

Publishing date: 
2010
Status: 
Current
Reference number: 
CH39
Available in print: 
No - PDF only
Further information: 

Synopsis

The NHMRC has re-issued the Joint statement and recommendations on vitamin K administration to newborn infants to prevent vitamin K deficiency bleeding in infancy.  Vitamin K is administered to newborns to prevent vitamin K deficiency bleeding (VKDB). 

The recommendations in the Joint statement and recommendations on vitamin K administration to newborn infants to prevent vitamin K deficiency bleeding in infancy remain unchanged after being widely consulted, including receiving advice from clinicians, government health departments, professional colleges and the Council of the NHMRC.

The NHMRC CEO approved the re-issuing of the Joint statement and recommendations on vitamin K administration to newborn infants to prevent vitamin K deficiency bleeding in infancy on 2 November 2010.

Related information: